Mitogen-activated protein kinase kinase 4 (MAP2K4) mRNA (MAP2K4 mRNA)

Mitogen-activated protein kinase kinase 4 (MAP2K4) mRNA is the transcript encoding the MKK4 protein, a dual-specificity kinase that plays a pivotal role in the JNK and p38 MAPK signaling pathways [UniProt, 2024]. In the liver, MAP2K4 acts as a critical negative regulator of hepatocyte proliferation; consequently, its mRNA has emerged as a high-priority therapeutic target for liver regeneration [Wuestefeld et al., Cell, 2013]. By utilizing RNA interference (RNAi) or antisense oligonucleotides to degrade MAP2K4 mRNA, researchers can transiently suppress MKK4 protein expression, thereby "releasing the brake" on the cell cycle and promoting compensatory growth in damaged liver tissue [HepaRegeniX, 2023]. This approach is particularly relevant for treating acute liver failure and chronic conditions like cirrhosis, where enhancing the liver's innate regenerative capacity is therapeutic [PubMed, 2021]. However, because MAP2K4 also functions as a tumor suppressor in certain contexts, the primary safety concern involves the potential for malignant transformation if suppression is not carefully controlled [Nature, 2013]. Additionally, therapeutic development requires sophisticated delivery systems, such as lipid nanoparticles, to ensure the RNA-targeting agents reach hepatocytes effectively while minimizing systemic side effects [NCBI, 2024].

Other names

MKK4 mRNASEK1 mRNAMAPKK4 mRNAJNKK1 mRNAPRKMK4 mRNADual specificity mitogen-activated protein kinase kinase 4 transcript

RNA interference-mediated degradation of the MAP2K4 transcript to reduce MKK4 protein expression and promote hepatocyte proliferation.